Amazon Buys SnapTell, Madrona Backs Animoto, MDRNA Works Out Tech License, & More Seattle-Area Deals News

6/23/09Follow @gthuang

It has been a fairly busy start to the summer in the Northwest. In the past week, we’ve seen a number of deals in software, Internet, displays, biotech, and energy.

—Portland, OR-based Reductive Labs raised a $2 million Series A round led by True Ventures in Palo Alto, CA. Reductive, whose founders are in Salt Lake City and Nashville, TN, but are relocating most of the company to Portland, has developed open source software to help companies automate the management of their IT systems. True Ventures is also an investor in Seattle-based 1000 Markets and RescueTime.

—Redmond, WA-based Microvision (NASDAQ: MVIS), a maker of display technologies, received a $15 million investment from Taipei-based Walsin Lihwa, in the form of a common stock sale to Walsin’s subsidiary, Max Display Enterprises Limited, and a warrant to buy more shares.

—Bellevue, WA-based LiquidPlanner, a collaborative software startup focused on online project management, raised $1 million from angel investors, including $235,000 from the Seattle-based Alliance of Angels’ new seed fund. Angel investor Geoff Entress has joined LiquidPlanner’s board of directors.

—Luke reported that Bothell, WA-based MDRNA (NASDAQ: MRNA), a developer of RNA interference drugs, renegotiated a key technology license with Denmark-based RiboTask. MDRNA now has full control and no longer needs to make payments for the technology, which could make RNA interference drugs more stable and less likely to cause inflammation. Terms of the deal were not disclosed.

—Seattle-based Madrona Venture Group led a $4.4 million funding round for Animoto, a New York-based video and slideshow software startup. Amazon is also an investor in the company, which … Next Page »

Gregory T. Huang is Xconomy's Deputy Editor, National IT Editor, and the Editor of Xconomy Boston. You can e-mail him at gthuang@xconomy.com or call him at 617-252-7323. Follow @gthuang

Single Page Currently on Page: 1 2

By posting a comment, you agree to our terms and conditions.